Commensal Clostridia carrying the bai operon, such as C. scindens, have been associated with protection against CDI; however, the mechanism for this protection is unknown. Herein, we show four commensal Clostridia that carry the bai operon and affect C. difficile growth in a strain-dependent manner, with and without the addition of cholate. Inhibition of C. difficile by commensals correlated with the efficient conversion of cholate to deoxycholate, a secondary bile acid that inhibits C. difficile germination, growth, and toxin production. Competition studies also revealed that C. difficile was able to outcompete the commensals in an in vitro coculture system. These studies are instrumental in understanding the relationship between commensal Clostridia and C. difficile in the gut, which is vital for designing targeted bacterial therapeutics.
Clostridioides difficile is an anaerobic pathogen that causes significant morbidity and mortality. Understanding the mechanisms of colonization resistance against C. difficile is important for elucidating the mechanisms by which C. difficile is able to colonize the gut after antibiotics. Commensal Clostridium play a key role in colonization resistance. They are able to modify bile acids which alter the C. difficile life cycle. Commensal Clostridium also produce other inhibitory metabolites including antimicrobials and short chain fatty acids. They also compete with C. difficile for vital nutrients such as proline. Understanding the mechanistic effects that these metabolites have on C. difficile and other gut pathogens is important for the development of new therapeutics against C. difficile infection (CDI), which are urgently needed.
Background: Clostridioides difficileis an enteric pathogen historically known to cause hospital associated (HA)-infections in humans. A major risk factor for CDI in humans is antibiotic usage as it alters the gut microbiota and there is a loss of colonization resistance againstC. difficile. In recent years there has been an increase in community associated (CA)-C. difficileinfection that does not have the same risk factors as HA-CDI. Potential sources of CA-CDI have been proposed and include animals, food, water, and the environment, however these sources remain poorly investigated. Here, we define the prevalence ofC. difficilestrains found in different companion animals (canines, felines, and equines) to investigate a potential zoonotic link.C. difficilestrains were identified by toxin gene profiling, fluorescent PCR ribotyping, and antimicrobial susceptibility testing. 16s rRNA gene sequencing was done on animal feces to investigate the relationship between the presence ofC. difficileand the gut microbiota in different hosts.Results: Here, we show thatC. difficilewas recovered from 20.9% of samples (42/201), which included 33 canines, 2 felines, and 7 equines. Over 69% (29/42) of the isolates were toxigenic and belonged to 14 different ribotypes, with overlap between HA- and CA-CDI cases in humans. The presence ofC. difficileresults in a shift in the fecal microbial community structure in both canines and equines. Commensal ClostridiaC. hiranoniswas negatively associated withC. difficilein canines. Further experimentation showed a clear antagonistic relationship between the two strainsin vitro, suggesting that commensalClostridiamight play a role in colonization resistance againstC. difficilein different hosts.Conclusions: In this study we investigated a potentially important source ofC. difficiletransmission: the companion animal population.C. difficilecarriage was common in dogs, cats, and horses.C. difficileisolates from companion animals included many of the same ribotypes known to cause HA- and CA-CDI in humans, and had similar antimicrobial resistance profiles as those isolated from human populations. These data contribute to our understanding of non-hospital exposure toC. difficilein the human population and suggest new avenues for reducingC. difficileprevalence in companion animals and, perhaps, thereby reducing CA-CDI in humans.
Clostridioides difficileis one of the leading causes of antibiotic-associated diarrhea. Gut microbiota-derived secondary bile acids and commensalClostridiathat encode the bile acid inducible (bai) operon are associated with protection fromC. difficileinfection (CDI), although the mechanism is not known. In this study we hypothesized that commensalClostridiaare important for providing colonization resistance againstC. difficiledue to their ability to produce secondary bile acids, as well as potentially competing againstC. difficilefor similar nutrients. To test this hypothesis, we examined the ability of four commensalClostridiaencoding thebaioperon (C. scindensVPI 12708,C. scindensATCC 35704,C. hiranonis, andC. hylemonae) to convert CA to DCAin vitro, and if the amount of DCA produced was sufficient to inhibit growth of a clinically relevantC. difficilestrain. We also investigated the competitive relationship between these commensals andC. difficileusing anin vitroco-culture system. We found that inhibition ofC. difficilegrowth by commensalClostridiasupplemented with CA was strain-dependent, correlated with the production of ∼2 mM DCA, and increased expression ofbaioperon genes. We also found thatC. difficilewas able to outcompete all four commensalClostridiain anin vitroco-culture system. These studies are instrumental in understanding the relationship between commensalClostridiaandC. difficilein the gut, which is vital for designing targeted bacterial therapeutics. Future studies dissecting the regulation of thebaioperonin vitroandin vivoand how this affects CDI will be important.Importance: CommensalClostridiaencoding thebaioperon such asC. scindenshave been associated with protection against CDI, however the mechanism for this protection is unknown. Herein, we show four commensalClostridiathat encode thebaioperon effectC. difficilegrowth in a strain-dependent manner, with and without the addition of cholate. Inhibition ofC. difficileby commensals correlated with the efficient conversion of cholate to deoxycholate, a secondary bile acid that inhibitsC. difficilegermination, growth, and toxin production. Competition studies also revealed thatC. difficilewas able to outcompete the commensals in anin vitroco-culture system. These studies are instrumental in understanding the relationship between commensalClostridiaandC. difficilein the gut, which is vital for designing targeted bacterial therapeutics.